Name: KRYS Income Statement - Krystal Biotech Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

KRYS - Krystal Biotech, Inc.

USD | NASDAQ | Healthcare

KRYS Income Statement - Krystal Biotech Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q3 FY 16
Revenues
Revenues	116.4	107.1	97.8	96.0	88.2	91.1	83.8	70.3	45.3	42.1	8.6	0.0	0.0	-	0.0	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Revenues
Revenues	417.3	389.1	290.5	50.7	0.0	0.0	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses
Research & Development	59.1	58.0	53.6	46.4	42.5	27.9	17.9	15.6	7.8	3.2	0.7
Selling General & Administrative	155.1	146.7
Operating Income
Operating Income	178.7	161.3	65.7	(109.6)	(145.2)	(68.3)	(33.0)	(22.1)	(11.9)	(4.8)	(1.1)
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-
Tax & Net
Income Tax Expense	(17.7)	(15.4)	6.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	-
Net Income From Continuing Ops	225.0	204.8
Per Share
EPS Basic	7.68	7.08	3.12	0.40	(5.49)	(3.13)	(1.71)	-	-	-	-
EPS Diluted	7.38	6.84	3.00
Supplementary Data
EBITDA	184.6	167.0	71.7	(104.6)	(141.1)	(65.5)	(31.1)	(21.0)	(11.8)	(4.7)	(1.1)
EBIT	178.7	161.3	65.7

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	15.3	14.8	14.6	14.4	14.3	13.5	13.5	15.6	11.0	11.4	10.6	12.1	12.3	10.7	11.5	10.9	9.3	9.0	6.1	6.6	6.2	5.7	5.1	3.6	3.5	4.3	3.9	4.2	3.2	2.8	1.9	1.5	1.5	1.1	1.4	0.4	0.3	0.2
Selling General & Administrative	41.0	41.4	37.6	35.2	32.6	31.3	28.7	27.6	26.1	24.7	23.7	25.9	24.0	-	19.9	-
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	25.9	24.0	24.0	19.9	17.9	15.9
Depreciation & Amortization	1.5	1.6	1.4	1.3	1.4	1.4	1.3	1.8	1.4	1.9	1.2	1.2	0.7	1.9	0.7	0.5
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	62.7	62.7	56.4	56.7	51.9	49.7	61.4	61.7	51.9	38.9	34.5	38.0	48.8	34.8	31.5	28.8

Operating Income
Operating Income	53.7	44.4	41.4	39.3	36.3	41.4	22.5	8.6	(6.7)	3.2	(26.0)	(38.0)	(48.8)	(34.8)	(31.5)	(28.8)	(50.2)	(21.9)	(15.7)	(16.4)	(14.4)	(10.4)	(9.7)	(7.0)	(5.9)	(6.2)	(5.3)	(5.9)	(4.7)	(4.2)	(3.0)	(2.4)	(2.3)	(1.5)	(2.1)	(0.7)	(0.5)	(0.3)

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	0.0	0.0	0.0	0.0
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pre-Tax Income	61.4	51.1	48.0	46.8	43.6	48.6	29.8	16.0	0.9	-	80.7	(33.2)	-	-	-	-	-

Tax & Net
Income Tax Expense	5.5	(0.3)	(31.4)	8.4	7.9	3.1	2.6	0.5	0.0	-	0.0	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income From Continuing Ops	55.9	51.4	79.4	38.3	35.7	45.5	27.2	15.6	0.9	8.7	80.7	(33.2)	(45.3)	(32.1)	(29.9)	(28.1)	(50.0)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	55.9	51.4	79.4	38.3	35.7	45.5	27.2	15.6	0.9	8.7	80.7	(33.2)	(45.3)	(32.1)	(29.9)	(28.1)	(50.0)
Net Income Attributable To Parent	55.9	51.4	79.4	38.3	35.7	45.5	27.2	15.6	0.9	8.7	80.7	(33.2)	(45.3)	(32.1)	(29.9)	(28.1)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	55.9	51.4	79.4	38.3	35.7	45.5	27.2	15.6	0.9	8.7	80.7	(33.2)	(45.3)	(32.1)	(29.9)

Per Share
EPS Basic	1.91	-	2.74	1.33	1.24	-	0.95	0.54	0.03	-	2.88	(1.25)	(1.76)	-	(1.17)	(1.10)	(1.99)	-	(0.70)	(0.74)	(0.74)	-	(0.49)	(0.37)	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Diluted	1.83	-	2.66	1.29	1.20	-	0.91	0.53	0.03	-	2.79	(1.25)	(1.76)	-	(1.17)	(1.10)	(1.99)	-
Shares Basic	29.3	-	29.0	28.9	28.8	-	28.7	28.6	28.3	-	28.0	26.7	25.7	-	25.6	25.5	25.1	-
Shares Diluted	30.5	-	29.8	29.7	29.9	-	29.9	29.6	29.3	-	28.9	26.7	25.7	-	25.6	25.5	25.1	-

Supplementary Data
EBITDA	55.2	46.0	42.8	40.6	37.7	42.8	23.8	10.4	(5.3)	5.1	(24.8)	(36.8)	(48.1)	(32.9)	(30.8)	(28.3)	(49.2)	(20.6)	(15.2)	(15.9)	(13.8)	(9.8)	(9.3)	(6.6)	(5.5)	(5.6)	(5.2)	(5.7)	(4.6)	(4.2)	(2.9)	(2.4)	(2.3)	(1.5)	(2.1)	(0.7)	(0.5)	(0.3)
EBIT	53.7	44.4	41.4	39.3	36.3	41.4	22.5	8.6	(6.7)	3.2	(26.0)	(38.0)	(48.8)	(34.8)	(31.5)	(28.8)	(50.2)	(21.9)	(15.7)